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A novel Joint Brain network 
Analysis Using Longitudinal 
Alzheimer’s Disease Data
Suprateek Kundu  *, Joshua Lukemire, Yikai Wang, Ying Guo & the Alzheimer’s Disease 
neuroimaging initiative*
There is well-documented evidence of brain network differences between individuals with Alzheimer’s 
disease (AD) and healthy controls (Hc). to date, imaging studies investigating brain networks in these 
populations have typically been cross-sectional, and the reproducibility of such findings is somewhat 
unclear. in a novel study, we use the longitudinal ADni data on the whole brain to jointly compute the 
brain network at baseline and one-year using a state of the art approach that pools information across 
both time points to yield distinct visit-specific networks for the AD and HC cohorts, resulting in more 
accurate inferences. We perform a multiscale comparison of the AD and Hc networks in terms of global 
network metrics as well as at the more granular level of resting state networks defined under a whole 
brain parcellation. our analysis illustrates a decrease in small-worldedness in the AD group at both the 
time points and also identifies more local network features and hub nodes that are disrupted due to 
the progression of AD. We also obtain high reproducibility of the Hc network across visits. on the other 
hand, a separate estimation of the networks at each visit using standard graphical approaches reveals 
fewer meaningful differences and lower reproducibility.
Alzheimer’s disease (AD) is one of the most common forms of dementia. An increasing emphasis is being 
placed on identifying biomarkers for the detection of AD at an early or pre-clinical stage in hopes of limiting 
the neuronal damage caused by AD. One such promising biomarker is disruptions in healthy patterns of resting 
state functional connectivity, which can be detected using resting state functional magnetic resonance imaging 
(rsfMRI)1–3. The National Institute on Aging–Alzheimer’s Association lists rsfMRI functional connectivity as a 
potential biomarker of neuronal injury, at an early stage of validation4.
One of the most popular approaches to investigating functional connectivity is using brain networks defined 
through a graph-theoretic approach that defines the brain network as a set of connections (known as edges) 
between brain regions (commonly called nodes). A graph or network G is characterized by its node set V  and 
edge set E . Given the node set = …V p{1, , }, the goal of a graph-theoretic approach for computing functional 
connectivity is to estimate the edge set E  using the fMRI data. Graph-theoretical studies of functional connectiv-
ity in HC and AD patients typically estimate the brain network separately for each individual or cohort and then 
examine differences in these networks to identify brain regions with disrupted connectivity in AD patients5,6. 
These differences can be investigated at different levels of granularity, such as at the edge level, node level, or at the 
level of global or local network metrics.
To date, graph theoretical studies of the brain network in HC and AD have been predominantly 
cross-sectional. However in recent years longitudinal studies have become increasingly popular in the neurosci-
ence community. By collecting baseline and follow-up data for each subject, longitudinal studies are well-known 
to have the potential to provide more reliable and significant scientific findings than cross-sectional studies. There 
has been some limited work on longitudinal analysis of brain connectivity, which mainly involves modeling 
pairwise connectivity measures or network summary measures from a pre-specified network structure7–9. Very 
recently, a small number of studies10–13 looked at longitudinal modifications in the AD network and compared 
these to network changes for HC and/or MCI groups. Compared to cross-sectional data, a key advantage in longi-
tudinal fMRI studies is that one can potentially use state of the art statistical methods to jointly estimate the brain 
networks over multiple visits by pooling information across visits. Joint estimation of multiple brain networks 
has recently been shown to result in greater power to detect the true edges and significant differences, compared 
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to the commonly used approach of separately estimating each network14. However, to our knowledge none of 
the existing AD studies have pooled information across visits to estimate cohort- and visit-specific networks. 
Moreover, few existing approaches used sparse precision (or inverse covariance) matrices, which provides a nice 
graph theoretic interpretation and is the focus of this paper. Such matrices encode conditional dependency rela-
tionships between measurements with off-diagonal zeros corresponding to absent edges.
The standard practice for comparing multiple brain networks is to estimate each brain network separately 
and then use mass-univariate hypothesis testing to infer significant differences between the networks while con-
trolling the family-wise error rate15–17. These approaches suffer from inflated false positive rates because of the 
massive number of multiple comparisons they use18, and they also possibly have reduced power to detect true 
differences between visits19. As an alternative to these large scale hypothesis testing procedures, network metrics 
and statistics have become quite popular for summarizing the large scale organization of the brain18–20. These 
techniques improve statistical power but come at the cost of reduced explanatory value since they typically do not 
provide inferences at the level of individual connections.
In order to take advantage of the benefits of pooling data across cohorts/visits for network estimation, there 
has been a recent growth in penalized approaches for the joint estimation of multiple graphical models. These 
include penalized approaches21–23 that only report point estimates and do not provide measures of uncertainty, 
and some Bayesian methods as in24 and25 that provide a convenient way to quantify uncertainty. However with 
the exception of some very recent work26, none of the existing approaches for the joint estimation of multiple 
networks have been applied to the problem on estimating multiple temporally dependent networks across longi-
tudinal visits, to our knowledge. Unfortunately, the approach by26 uses a regression based model that is unable to 
produce a positive definite precision matrix which is key to quantifying the edge strengths.
Our study is motivated by the longitudinal ADNI data, which contains rsfMRI measurements for each indi-
vidual (belonging to HC or AD cohorts) at baseline and follow-up visits. Using this data, one can compute and 
compare the brain networks for the AD and HC cohorts at each visit by pooling information across visits using 
graph theoretic approaches. While some limited variations are expected in both networks due to the inherent 
variability in the data, we expect to see systematic longitudinal differences in the AD network between baseline 
and the follow-up visits due to the progression of the disease. Network differences between cohorts that are con-
sistent across visits, as well as similarity of the HC network between visits, would be suggestive of reproducible 
findings that are robust to noise inherent in the fMRI data. Our focus in this work is on (i) inferring network 
changes between the two cohorts at each visit; (ii) evaluating whether such network differences between cohorts 
are consistent across the two visits, and (iii) understanding the longitudinal network changes for the AD indi-
viduals and assessing network reproducibility for the HC cohort across visits. We would also like to compare the 
above findings in relation to the results obtained under an alternate analysis involving the separate estimation of 
the network for each cohort and visit using standard graphical modeling approaches. Some key contributions of 
this article are:
•	 We propose a graph theoretic analysis of the network changes in AD individuals compared to the HC network 
at baseline and one-year follow-up using longitudinal ADNI rsfMRI data.
•	 We use the cutting edge Bayesian joint network learning (BJNL) approach14 to jointly estimate the brain net-
works at the two visits for each cohort. The joint learning is able to detect a better separation between the AD 
and HC networks and leads to more reproducible estimates for the HC network. In contrast, a separate esti-
mation of each cohort- and visit-specific network suggests a lack of separation of the HC and AD networks 
and poor reproducibility of the HC network across visits.
•	 Our analysis provides a multiscale understanding of the network changes between AD and HC networks, at 
the level of global network metrics, as well for the more local resting state networks and hub nodes. We illus-
trate the loss of small-world properties as well as the disruption of other global network metrics in the AD 
network, and identify the hub nodes responsible for the greatest disruptions.
Our analysis results make a strong case for the merits of joint estimation of longitudinal networks by pooling 
data across visits. To our knowledge, this work is one of the first such studies to illustrate the benefits of joint 
analysis in brain network estimation using longitudinal neuroimaging data.
Methods
Description of the data. Rs-fMRI description. We applied the BJNL method to the longitudinal rsfMRI 
data from the Alzheimer’s Disease Neuroimaging Initiative 2 (ADNI2) study. One of the main purposes of the 
ADNI2 project is to examine changes in neurobiology with the progression of AD. Data used in our analysis were 
downloaded from the ADNI website (http://www.adni.loni.usc.edu) and included longitudinal rs-fMRI images 
that were collected at baseline screening and 1 year follow-up, for 17 individuals with AD, and 27 healthy controls 
(HC). Although data was also available for a second follow-up visit at year 2, we limit our analysis to scans from 
baseline and one-year, since the sample size for individuals with data at all three visits was fairly small. More 
detailed descriptions of the demographic and clinical features of the participants are provided in Table 1. The 
acquisition protocol and pre-processing steps for the imaging data are described in the Supplementary Materials.
We note that the sample size used for our analysis is comparable to other recent longitudinal analyses using 
ADNI data, although none of the existing studies have looked at longitudinal brain network changes using resting 
state fMRI data jointly from multiple visits. For example27, analyzed resting state fMRI data from ADNI involving 
30 healthy controls (17 females and 13 males) and 26 AD patients (11 females and 15 males). Also9 performed a 
longitudinal analysis of resting state connectivity using data from ADNI 2 with 10 AD and 23 HC individuals13. 
proposed a longitudinal independent component analysis using an even smaller sample size from ADNI 2 study. 
In another study involving 40 participants (5 AD, 16 MCI and 19 HC)28, used longitudinal PET data at baseline 
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and two year followup from ADNI GO and ADNI 2 databases, to study changes in white matter hyperintensities. 
As in the above studies, the moderate sample size for our analysis is sufficient to detect important network differ-
ences between the AD and HC cohorts.
Power atlas and resting state networks. The preprocessed fMRI data was summarized into the 264 node system 
specified by the Power atlas in29. The Power atlas29 is based on functional systems of brain activity identified using 
task and resting-state fMRI. As a further level of parcellation, each node was assigned to one of 10 resting state 
networks (RSNs) identified in30 using the technique described in31. The RSNs used and number of nodes in each 
RSN (in parenthesis) were as follows: medial visual network (15), occipital pole visual network (15), lateral visual 
network (19), default mode network (20), cerebellum (6), sensorimotor (31), auditory (29), executive control 
(39), right frontoparietal (32), left frontoparietal (26), and the remainder of the nodes were assigned as unknown 
(32). We also note that the Cerebellum has an extremely small number of nodes, which may potentially result 
in extreme (and potentially unreliable) values of some network metrics as seen from the results presented in the 
article.
Bayesian joint network learning. Recently14, proposed the BJNL approach to jointly estimate multiple 
networks under a Bayesian framework. BJNL models the edge probabilities as a flexible function of shared com-
ponents that are common across all networks and differential components unique to each specific network. The 
approach provides a convenient framework to pool information across multiple networks to model edges with-
out enforcing similarity of the edge strengths across networks. It is automatically able to provide measures of 
uncertainty and yield positive definite precision matrix estimates that can be used to systematically quantify edge 
strengths. In their paper14, showed the BJNL approach could result in substantial improvements for the estima-
tion of multiple networks corresponding to different cognitive states in a visual experiment, compared to other 
existing approaches that estimate multiple networks jointly or separately. In this article, we use the BJNL approach 
for analyzing the longitudinal ADNI data, in order to jointly estimate cohort- and visit-specific resting state brain 
networks corresponding to the baseline and one-year follow-up visits for AD individuals and separately for HC 
subjects.
The BJNL approach relies on a Gaussian graphical model (GGM) to fit the brain functional network based on 
the fMRI measurements which are assigned a Gaussian distribution characterized by a sparse inverse covariance 
matrix. That is, the prewhitened fMRI measurements y are modeled: Ω−~ GNy 0( , )
1 , where the off-diagonal ele-
ments of Ω are assigned zeros corresponding to absent edges in the network G. As in14, we use a autoregressive 
model to prewhiten the fMRI measurements (i.e. minimize temporal correlations) in order to satisfy the inde-
pendence assumption typically required for GGMs. The goal of a GGM is to estimate a sparse precision matrix 
from the data, which automatically enables one to infer the estimated network Gˆ simply by examining which 
elements of the precision matrix are non-zero. The BJNL approach that we are going to use for our analysis is 
based on the joint estimation of multiple GGMs. The parameters are sampled iteratively using Markov chain 
Monte Carlo (MCMC), and the MCMC samples are aggregated to obtain parameter estimates and report credible 
intervals that quantify uncertainty. An overview of the BJNL method is provided in the Supplementary Materials; 
we refer the reader to14 for full details.
One potential pitfall of our approach is that it views the data at the group level, which does not account for 
subject-level heterogeneity in the brain networks. A possible approach for accounting for heterogeneity is to 
model individual specific networks as a function of covariates, that will also enable one to pool information across 
subjects when estimating the covariate effects on the networks. However, such an approach is methodologically 
challenging, and to our knowledge, most of the existing methods for joint estimation of Gausssian graphical mod-
els can not directly incorporate covariate information when estimating multiple networks. Moreover, our focus in 
this article is on group level comparisons, and we expect the effects of covariates such as age, sex, and education, 
on the cohort level network differences to balance out (by design) when comparing the AD and HC groups having 
similar distributions of the covariates. Hence, although we did not explicitly account for age, sex, and education 
when modeling the networks, these variables are not expected to drive any important differences between the AD 
and HC networks, since the composition of the cohorts with respect to the covariates are similar.
N
HC EMCI LMCI AD
27 24 23 17
Baseline Age (sd) 74.02 (5.88) 71.62 (5.66) 71.38 (7.21) 73.91 (8.48)
Sex (% Female) 55.6 37.5 43.5 58.8
Education (sd) 16.26 (2.12) 15.96 (2.46) 16.48 (2.45) 14.88 (2.62)
APOE4 (number with)
   0 17 12 15 2
   1 9 9 5 9
   2 1 3 3 6
Amyloid (% Positive) 26.9 58.3 60.9 100
Table 1. Demographics table for the healthy controls (HC), early MCI (EMCI), late MCI (LMCI), and 
Alzheimer’s disease patients (AD). One HC individual had missing amyloid status.
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Graph metrics and small world organization. We use the BJNL approach to pool data across visits 
in order to compute visit-specific networks for the AD and HC cohorts. Using these computed networks, we 
perform a multi-scale analysis of the differences in the AD and HC networks at baseline and one-year follow-up 
using network metrics at the global network level, as well as at the level of RSNs and nodes. These metrics were 
computed using the Brain Connectivity Toolbox32, and allow us to use single numbers to summarize efficiency 
of information transmission and other aspects of brain network organization such as small-worldedness and 
clustering. For our analysis, we focused on global efficiency (GE), local efficiency (LE), characteristic path length 
(CPL), mean clustering coefficient (MCC), and small-worldedness, which were calculated based on the estimated 
adjacency matrices from BJNL. Adjacency matrices refer to binarized matrices with off-diagonal ones corre-
sponding to edges in the network and off-diagonal zeros otherwise. A description of the metrics used is provided 
in the Supplementary Materials.
We note that the CPL and GE metrics are inversely proportional (i.e. a higher GE implies smaller CPL and 
vice-versa), and both these metrics are related to the small-worldedness of the network. Our goal is to use the pre-
viously defined metrics to investigate the disruption of the AD network compared to the HC network at baseline 
and one-year follow-up, and to identify the nodes and RSNs responsible for the greatest disruptions. In particular, 
we also examine some RSN-specific metrics that help us identify which RSNs result in the greatest differences in 
brain organization between the AD and HC networks at baseline and one-year follow-up. On the other hand, a 
node attack approach is used to detect nodes with the highest disruptive potential (see below). These comparisons 
are designed to provide a multiscale understanding of the network disruptions in AD and how it modifies infor-
mation transmission in the brain.
Metrics for identification of hub nodes. Hub nodes are generally identified by how often a node appears in the 
shortest path of other nodes or by how many of a node’s connections are to nodes in RSNs other than the RSN 
to which that node belongs. We used the Brain Connectivity Toolbox to calculate the participation coefficient 
and betweenness (described in the Supplementary Materials), both of which are node-specific metrics that can 
identify hub nodes.
node attack approach. To study the node-specific contributions to information transmission, we use a 
node attack approach33,34 where we cycle through each node in the brain and remove all edges to that node, effec-
tively disconnecting it from the brain network. Then, we recalculate the global network metrics on the resulting 
network and identify the important nodes as those responsible for the maximum disruptions when they are dis-
connected from the network. In a small-world network, deletion of a randomly selected node is not expected to 
have much influence on most network metrics due to the fact that most information transmission runs through a 
small number of hub nodes. On the other hand, if the deleted node is a hub node, then we expect to see a signifi-
cant changes in the network metrics. The nodes resulting in the highest reductions in the metrics were identified 
and listed in Tables 2–4.
Assessing statistically significant differences. The statistically significant differences between net-
works are assessed by constructing credible intervals for each of the quantities of interest and examining the 
100(1 − α)% credible intervals obtained using MCMC sampling from the posterior distributions BJNL approach 
in the. An overlap of the credible intervals implies non-significant differences for the metrics, whereas no overlap 
implies significant variations. In order to adjust for the multiple comparisons (baseline vs. one-year for each met-
ric (10) and HC vs. AD for each metric (5)), we use a multiplicity adjusted threshold α = 0.01/15 = 0.0008 due to 
Bonferroni correction. For testing differences in nodal metrics such as betweenness and participation coefficient, 
whose posterior distributions are not normal and the separation in the posterior distributions between cohorts 
is not clear, we use Wilcoxan signed-rank test that is a non-parametric test free of distributional assumptions.
Node RSN HC Baseline HC One-year AD Baseline AD One-year AD − HC Baseline AD − HC One-year
85 SM −1.04 −1.16 −0.85 −0.83 0.18 0.32
81 SM −1.00 −1.08 −0.91 −0.86 0.09 0.21
51 DMN −1.06 −0.96 −0.88 −0.86 0.19 0.09
64 DMN −0.96 −1.06 −0.94 −0.85 0.03 0.2
137 EC −0.97 −1.02 −0.83 −0.82 0.14 0.2
166 EC −0.98 −0.88 −0.82 −0.78 0.16 0.11
59 DMN −0.98 −0.98 −0.79 −0.81 0.18 0.17
143 EC −0.97 −0.94 −0.85 −0.82 0.12 0.12
70 Cerebellum −0.95 −0.84 −0.77 −0.77 0.18 0.07
71 Cerebellum −0.95 −0.85 −0.81 −0.83 0.13 0.02
Table 2. Top 10 largest percent change in global efficiency upon removal of a node in HC and AD. The final two 
columns display the difference in percent loss between AD and HC at that node at baseline and at one−year. 
All of the differences between AD and HC are positive, indicating that HC saw a larger reduction in global 
efficiency.
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Reproducibility of the network. In order to evaluate the overlap of the estimated AD and HC networks 
over the two visits (baseline and one-year follow-up), we investigated the consistency of hub nodes over time 
using Cohen’s kappa coefficient35. We defined hub nodes as nodes where the normalized betweenness score was 
1.5 standard deviations above the mean34,36. We varied the threshold of normalized betweenness required to call a 
node a hub node from the minimum to the maximum value and calculated the kappa coefficient for each thresh-
old. Bigger values of the threshold imply a smaller number of hub nodes having many connections, and larger 
values of the kappa coefficient indicate agreement across time points in what can be considered hub nodes. The 
results for the hub nodes are presented in Fig. 1. To obtain a more general assessment of agreement between net-
works across visits, we also computed the reproducibility for several network metrics across visits using a measure 
known as intraclass correlation coefficient or ICC37. Using the measure ICC, we investigate the reliability of graph 
metrics across two scanning sessions38,39. This metric is commonly used to measure test-retest network stability 
in brain networks37 with agreement scale 0 < ICC ≤ 0.2(slight), 0.2 < ICC ≤ 0.4 (fair), 0.4 < ICC ≤ 0.6 (moderate), 
0.6 < ICC ≤ 0.8 (strong), and 0.8 < ICC ≤ 1 (near perfect) as suggested by39.
ICC is usually derived by calculating the proportion of the total variation attributed to variability across scan-
ning sessions. Thus, small variation across sessions produces high ICC values, indicating strong reproducibility. 
In network estimation problems for neuroimaging applications, one expects strong reproducibility across differ-
ent scanning sessions for networks with no systematic changes between time points (such as in healthy controls), 
but such reproducibility is not expected in networks for diseased individuals where the progression of the disease 
(e.g. AD) is likely to alter the network for the same individual across visits.
Results
estimated connectivity. The estimated adjacency matrices for HC and AD are presented in Fig. 2. The 
connections are colored based on the sign of the corresponding partial correlation. We identified 6444 and 6029 
edges in HC at baseline and one-year follow-up respectively, that represent 18.6% and 17.4% of the possible 
connections in the network. We identified 8049 and 8401 edges in AD at baseline and one-year follow-up respec-
tively, that represent 23.2% and 25.2% of the possible connections in the network. Hence the densities of the 
estimated networks are well within the range of network densities expected in practical fMRI applications37. From 
Fig. 2, it is fairly evident that the HC network has a smaller number of connections that are mostly concentrated 
within RSNs, while the AD network has a greater number of between-RSN connections and in general the AD 
Node RSN HC Baseline HC One-year AD Baseline AD One-year AD − HC Baseline AD − HC One-year
*211 FPR −0.5 −0.77 −0.58 −0.52 −0.08 0.25
*27 Occ Pole −0.75 −0.49 −0.25 −0.43 0.5 0.06
*236 Unk −0.39 −0.74 −0.53 −0.47 −0.13 0.27
*228 FPR −0.55 −0.57 −0.7 −0.45 −0.15 0.12
81 SM −0.21 −0.33 −0.69 −0.66 −0.48 −0.34
210 FPR −0.37 −0.64 −0.56 −0.69 −0.19 −0.05
*195 FPL −0.67 −0.69 −0.69 −0.67 −0.01 0.01
183 FPL −0.45 −0.33 −0.68 −0.51 −0.23 −0.17
208 FPR −0.27 −0.68 −0.42 −0.51 −0.15 0.18
191 FPL −0.44 −0.31 −0.53 −0.65 −0.09 −0.34
Table 4. Top 10 largest percent change in MCC upon removal of a node in HC and AD. Positive (negative) 
values indicate that removal of this node increased (decreased) the MCC. The final two columns display the 
difference in percent change between AD and HC at that node at baseline and at one-year. A * before a node 
indicates that it was not a hub in any of the cohorts/visits.
Node RSN HC Baseline HC One-year AD Baseline AD One-year AD − HC Baseline AD − HC One-year
85 SM 0.37 0.54 0.1 0.07 −0.28 −0.47
81 SM 0.34 0.44 0.17 0.09 −0.17 −0.35
51 DMN 0.44 0.29 0.14 0.11 −0.3 −0.18
64 DMN 0.29 0.41 0.24 0.1 −0.05 −0.31
137 EC 0.29 0.34 0.08 0.07 −0.21 −0.27
59 DMN 0.3 0.28 0.05 0.06 −0.25 −0.22
166 EC 0.29 0.17 0.05 0.02 −0.24 −0.15
143 EC 0.29 0.23 0.09 0.06 −0.2 −0.17
30 Occ Pole 0.27 0.18 0.04 0.03 −0.23 −0.15
71 Cerebellum 0.26 0.13 0.06 0.07 −0.2 −0.06
Table 3. Top 10 largest percent change in CPL upon removal of a node in HC and AD. Positive (negative) 
values indicate that removal of this node increased (decreased) the CPL. The final two columns display the 
difference in percent change between AD and HC at that node at baseline and at one-year.
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network connections are more randomly distributed. In comparison to 40.1% and 40.0% connections that were 
contained within RSNs for the HC network at baseline and one-year, only 30.3% and 30.3% of the connections 
were contained within RSNs for the AD network at baseline and one-year.
Graph metrics and small-worldedness. The posterior densities for the graph metric results are presented 
in Fig. 3. There is no overlap in the estimated densities for the network metrics between the HC and AD groups 
both at baseline and one-year follow-up, with the exception of some minimal overlap in average local efficiency 
between the HC One-Year and AD groups. These results indicate significant differences between the AD and HC 
networks (p < 0.01 in all cases, Bonferroni corrected), which is somewhat expected based on evidence in existing 
literature.
These findings imply a greater clustering tendency and higher local efficiency at the node level in the HC 
network, compared to the AD network. The increased MCC for the HC network reflects the tendency of the 
connections to be clustered within RSNs (as evidenced by the adjacency matrix plot in Fig. 2). A greater MCC is 
also explained by the presence of a much larger number of hub nodes (Table 5), indicating the propensity of the 
edges to be clustered around a subset of important regions in the brain. Our findings in Fig. 3 also imply a greater 
small-world organization for the HC network, which is consistent with existing evidence in the literature40,41, and 
supports our hypothesis that the AD network is more closer to a random network compared to the HC network.
Surprisingly, the AD network seems to have a smaller CPL and larger GE at a global level, compared to the HC 
network. Both of these metrics measure the efficiency of information transmission, which is typically thought to 
be higher in the HC network compared to the AD network. In order to investigate the reason for this paradoxical 
result, we examined the GE and CPL values for each RSN in the AD and HC networks. Boxplots of the GE and 
CPL within each resting-state network are presented in Fig. 4 for each cohort averaged over visits. The results 
indicate that when looking at the metrics within RSN, the observed differences tend to largely go away except 
the FPR functional module in which the efficiency is significantly greater under the HC network. Our findings 
imply that the efficiency of information transmission in the HC network is largely similar within each RSN, and 
that the paradoxical findings in Fig. 3 can be attributed to a large number of between RSN connections under the 
AD network that are absent in the HC network (Fig. 2). We note that earlier findings have directly implicated the 
fronto-parietal regions in the progression of AD (see review by42).
Last, but not the least, the network metric differences between the AD and the HC networks are consist-
ent across baseline and one-year follow-up. It is also of interest to note the much greater overlap of the global 
efficiency and small worldedness at baseline and one-year follow-up for the HC group, compared to the AD 
network, in Fig. 3. The overlap of the HC network across baseline and one-year follow-up is also reflected by the 
consistency of the hub nodes in Fig. 1, as identified using the betweenness coefficient. The Figure clearly illus-
trates the consistently greater agreement of the hub nodes under the HC networks across almost all thresholds 
for the betweenness coefficient, which implies greater similarity between the baseline and one-year HC net-
works, potentially due to the preservation of small-worldedness across visits. On the other hand, the AD network 
demonstrates increased separability across visits in terms of global efficiency and small worldedness in Fig. 3, as 
well as poor agreement of the hub nodes in Fig. 1, both of which are indicative of the progression of AD and the 
more random nature of the network.
Reproducibility for the Hc network. Under our analysis, the computed ICC values under the HC net-
work at baseline and one-year follow-up for the betweenness coefficient, participation coefficient, nodal degree, 
Figure 1. Kappa agreement statistics by normalized betweenness required to call a node a hub node for HC 
and AD.
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local efficiency, and clustering coefficient were 0.80, 0.81, 0.82, 0.76, and 0.85, respectively. Clearly, the high ICC 
values over a range of local network metrics point towards a strong to near perfect reproducibilty of the HC net-
work between baseline and the one-year follow-up visit, as would be expected in a healthy brain that is experienc-
ing few connectivity changes over time. However, the high ICC values are also indicative of the robustness of the 
BJNL procedure, especially when contrasted with the considerably lower ICC values under an alternate analysis 
involving a separate estimation of the networks under the graphical lasso (see below).
Role of hub nodes. Figure 5 displays histograms of the posterior mean normalized betweenness and par-
ticipation coefficient for each node that were used to determine hub nodes. Because the distributions of the 
values across the nodes do not appear to be normally distributed, we use a Wilcoxan Signed-Rank test to test 
for significant differences between the two cohorts. We find significant differences in normalized betweenness 
(p = 1.48 × 10−5), and also for the participation coefficient (p < 2.2 × 10−16), between the HC and AD networks. 
These results support the findings presented in Table 5 and Fig. 2 that illustrate a greater number of hub nodes, 
and the smaller number of between RSN connections in the HC network. The spatial locations of the hub nodes 
are displayed in Fig. 6.
Figure 2. Estimated adjacency matrices for HC and AD at baseline and one-year follow-up. The edges 
are colored by the sign of the partial correlation (blue = negative, red = positive). There are 6444 and 6029 
estimated edges in HC at baseline and one-year follow-up respectively. There are 8049 and 8401 estimated 
edges in AD at baseline and one-year follow-up respectively. Edges in AD network appear to be more 
randomly distributed compared to the HC network, which has more within RSN connections and fewer 
between RSN connections. The RSNs are abbreviated follows: medial visual network (Med vis), occipital 
pole visual network (Occ pole), lateral visual network (Lat vis), default mode network (DMN), cerebellum 
(Cerebellum), sensorimotor (SM), auditory (Aud), executive control (EC), right frontoparietal (FPR), left 
frontoparietal (FPL), and unknown (Unk).
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A list of all hub nodes identified by cohort and visit is provided in Table 6 and represented in Fig. 6. The 
highest number of hub nodes for the HC network were detected in the default mode network (DMN) and the 
executive control (EC). However, in the AD group a fewer number of hubs were identified in these RSNs, with 
the exception of the AD group at baseline, which still showed four hubs in the EC at baseline, but this count had 
reduced to two by one-year follow-up. Literature has suggested changes in DMN activity that distinguishes AD 
from a healthy aging cohort43, and differences in the EC network have also been identified44. Table 5 also illus-
trates that no hub nodes corresponded to the remaining nodes with an unallocated RSN, which validates the use 
of the pre-specified RSNs for our analysis.
The participation coefficient across all nodes were 0.684, 0.690, 0.775, 0.782 in HC Baseline, HC One-Year, 
AD Baseline, and AD One-Year networks respectively. Interestingly, these results are inconsistent with what has 
been seen in the literature, which has often found a higher participation coefficient in HC subjects than in AD 
patients45,46. This discrepancy may be explained due to using different number of nodes and a different parcella-
tion scheme used in our analysis. Specifically, unlike many studies that examine participation coefficient under 
Figure 3. Graph metrics for each cohort as identified by BJNL.
Cohort/Visit #Hub Med Vis Occ Pole Lat Vis DMN Cerebellum SM Aud EC FPL FPR Unk
HC - Baseline 20 0 2 0 5 2 2 1 4 2 2 0
HC - One-Year 23 0 4 0 4 0 3 2 5 3 2 0
AD - Baseline 14 0 3 0 2 0 3 2 4 0 0 0
AD - One-Year 14 0 2 0 2 1 4 3 2 0 0 0
Table 5. Hubs in each cohort and visit identified using a normalized betweenness score 1.5 standard deviations 
above the mean organized by resting state network.
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data-defined modules, our study used the pre-defined RSN modules of30. Our study also uses a larger number 
of brain regions (264 nodes under the Power atlas) compared to than many other studies. Although contrary to 
the findings in existing literature, a smaller participation coefficient under our method is actually more consist-
ent with increased small-worldedness properties under the HC network and greater randomness under the AD 
network. In particular, a higher participation coefficient may be explained by a greater number of connections 
between RSNs compared to within RSNs under the AD network that is indicative of a greater randomness in the 
network.
Node-specific disruptions. The results of the node disruptions are presented in Fig. 7, which illustrates the 
histogram of the percent change in the metrics when one node is removed (top row), and the histogram of the 
percent change at the node level between the cohorts at each visit (bottom row). On the whole brain level, individ-
ual node removals had larger reductions in GE and CPL for the HC network (as evidenced by longer tails) which 
implies greater disruptions. This is indicative of the importance of hub nodes in the HC network that results in 
Figure 4. Boxplots of Global Efficiency and CPL within each resting-state network over MCMC iterations.
Figure 5. Histograms of the posterior mean for betweenness and participation coefficient across nodes. Note 
that only the 239 nodes belonging to a RSN were used to calculate the participation coefficient.
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greater clustering tendency and lesser randomness compared to the AD network. To compare the node-level dis-
ruptions across cohorts we also plotted the difference in the percent changes in GE and CPL between the AD and 
the HC networks (bottom row in Fig. 7). Examination of these node-wise difference show that there are several 
nodes with relatively large differences between AD and HC at both baseline and one-year follow-up, and that 
attacks on these nodes disrupt the GE and CPL in the HC network more than for the AD network, as evidenced 
by longer tails in Fig. 7.
The 10 nodes with the largest disruption effects for the HC cohort is displayed in Tables 2 and 3. Figures 8 and 
9 display the corresponding locations in the brain. Interestingly, all of these nodes responsible for the greatest dis-
ruptions in GE are also hub nodes in Table 5. Similarly, all nodes resulting in the greatest disruption in CPL upon 
disconnection are also hub nodes in Table 5 and nine of these hub nodes are also important disruptors of GE in 
Table 2. These results support our hypothesis that the organization of the HC network is primarily dependent on a 
set of hub nodes, which when removed cause the largest disruptions in information transmission, and is support-
ive of the small-worldedness properties of the HC network. We note that the nodes with the highest disruptive 
power in terms of GE and CPL are all contained in the DMN, EC, SM, and Occ Pole RSNs, which also contain the 
largest number of hub nodes in the HC network in Table 5.
comparison with graphical lasso analysis. As an illustrative comparison, we conducted a similar anal-
ysis using the graphical lasso47, which estimates each cohort- and visit-specific network separately. We selected 
the tuning parameters of the graphical lasso to achieve network densities similar to the BJNL results, for a mean-
ingful comparison. Figure 10 displays the estimated adjacency matrices from this approach. It is apparent that 
the graphical lasso estimates networks with a very different structure, and both the AD and HC networks seem 
to have more uniformly distributed connections that is indicative of a random network. Unlike the networks 
identified using BJNL which primarily had connections within RSNs, the graphical lasso produced network esti-
mates with a significantly larger number of the edges are between resting state networks. For the HC network, 
only 17.3% and 18.9% of the edges belonged to within RSN connections, whereas for the AD network, the corre-
sponding numbers were 15.8% and 15.9%. It is evident that there is almost a 50 percent reduction in the number 
of within RSN connections for the HC network under Glasso compared to BJNL, and similar large reductions are 
also observed in the AD network. This is potentially indicative of a more diffuse information transmission and 
decreased efficiency in network organization.
A large number of between RSN connections affect the ability to determine differences in the small-world 
network organization of the brain. Under the graphical lasso, point estimates of the small-worldedness in HC 
were 1.29 and 1.49 at baseline and one-year respectively, whereas those under the AD network were 1.30 and 1.22 
at baseline and one-year respectively. Clearly, the separation between the small-worldedness values between the 
AD and HC networks is not nearly as distinct as it was for BJNL. The above findings point to a potentially reduced 
power under the graphical lasso to detect differences in small-worldedness between the AD and HC networks.
Figure 6. Hub nodes within the brain for each cohort and visit as identified using BJNL and the graphical lasso. 
The nodes are colored by resting state network.
Cohort/Visit Node Index of Hub Nodes
HC - Baseline 18, 30, 51, 52, 59, 64, 69, 70, 71, 81, 85, 112, 137, 143, 149, 166, 177, 181, 207, 212
HC - One-Year 18, 19, 20, 30, 51, 59, 64, 67, 81, 85, 88, 124, 135, 137, 141, 143, 164, 166, 177, 181, 184, 207, 210
AD - Baseline 18, 19, 20, 51, 64, 81, 85, 99, 132, 135, 137, 143, 149, 152
AD - One-Year 18, 19, 51, 64, 71, 81, 85, 99, 106, 118, 124, 132, 137, 141
Table 6. Hubs in each cohort and visit identified using a normalized betweenness score 1.5 standard deviations 
above the mean.
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We also note that unlike BJNL, the HC networks at baseline and one-year under the graphical lasso illustrate 
weak reproducibility in terms of several network metrics. Under the graphical lasso analysis, the ICC values for 
betweenness, participation coefficient, nodal degree, local efficiency, and clustering coefficient for the HC net-
work are 0.74, 0.63, 0.84, 0.11, and 0.39 respectively. While the ICC values for the first three metrics are reason-
able, those for local efficiency and clustering coefficients are very weak, pointing to the difficulties of obtaining 
reproducible networks under the graphical lasso. This is potentially caused due to the more random nature of the 
estimated networks under the graphical lasso, and the inability of the approach to pool information across visits.
Finally, Tables 7 and 8 display the global efficiency and characteristic path length for a node disruption anal-
ysis under the graphical lasso, which is identical to the analysis conducted under BJNL. Figures S1 and S2 in the 
Supplementary Materials display the corresponding locations in the brain. Unlike the BJNL results in Table 2, 
the disruption in GE upon disconnection of a node is much more identical between the AD and HC network at 
baseline, implying greater overlap and smaller differences. Additionally, the CPL results in Table 8 show more 
nuanced disruptions under the graphical lasso. In particular, the sign of the changes in both GE and CPL can 
be both positive and negative, implying inconsistencies in the direction of change. Moreover, the maximum dis-
ruption potential for CPL under the graphical lasso analysis often do not coincide with the hub-nodes. These 
results potentially imply less meaningful interpretations under the alternative graphical lasso analysis that fail to 
Figure 7. Global Efficiency and CPL results for the node disruption analysis. The top row plots histograms 
of the percent change in each metric after removing each node. The bottom row displays histograms of the 
node-specific difference between the percent change the the AD cohort and the percent change in the HC 
cohort across all nodes. Because all percent changes in GE were negative upon removal of a node, a positive 
value of this difference indicates that global efficiency was more affected in HC when that particular node was 
disconnected. Similarly, a negative value indicates that GE was more disrupted in AD network compared to 
the HC network when this node was disconnected. negative values for the difference in percent change in CPL 
between the AD and HC network upon disconnection of a node indicates that CPL increased more in the HC 
network.
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Figure 8. Locations of the nodes with the top 10 largest percent change in GE upon removal in HC and 
AD under BJNL. The nodes are colored by resting state network. Most of these nodes also exhibited strong 
differences in the magnitude of the percent change between AD and HC at baseline and one-year. See Table 2 
for the corresponding values.
Figure 9. Locations of the nodes with the top 10 largest percent change in CPL upon removal in HC and 
AD under BJNL. The nodes are colored by resting state network. Most of these nodes also exhibited strong 
differences in the magnitude of the percent change between AD and HC at baseline and one-year. See Table 3 
for the corresponding values.
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elucidate the small-worldedness properties and highlight the role of hub nodes in the HC network, and does a 
relatively poor job of finding differences between the HC and the AD networks.
Discussion
There was a clear increase in the number of connections between RSNs in AD as compared to HC under BJNL. 
Interestingly, it appears that the majority of these connections were strongly negative in the AD network. The 
increase in between-RSN edges in the AD network is consistent with the hypothesis that the AD brain behaves 
more like a random network than a small-world network. This behavior of the AD brain networks has been 
hypothesized to be potentially due to disruption of hub nodes in the brain41. We discovered the higher nodal dis-
ruptions in GE and CPL under the HC network, compared to the AD network, and noted that the hub nodes were 
responsible for the greatest disruptions in GE and CPL. This is not surprising since the HC network has many more 
hub nodes and exhibits greater small-worldedness than the AD network that is much closer to a random network. 
Moreover, the decrease in the number of hub nodes and small-worldness under the AD network from baseline to 
one year, in contrast to a minimal change in the HC network with respect to these metrics, suggests progression 
of the AD disease within a span of one-year. In addition, the BJNL analysis discovered a much higher agreement 
for hub nodes across visits under the HC network (Fig. 1) and also indicated high ICC values for several network 
metrics, which suggests strong reproducibility for the HC network across visits. On the other hand, an alternate 
analysis that separatel analyzes data from each visit using graphial lasso discovered less meaningful differences 
between HC and AD cohorts and a weaker agreement for hub nodes in the HC cohort between two visits (Table 9).
One possible source of heterogeneity is the presence of amyloid, which has been associated with changes in 
functional connectivity. In our analysis, all of the AD patients were amyloid positive, while the HC cohort was 
split into 19 amyloid negative and 7 amyloid positive individuals. To examine whether amyloid status influences 
the HC network, we performed an additional subject-level analysis where we used the graphical lasso to estimate 
Figure 10. Estimated adjacency matrices for HC and AD at baseline and one-year follow-up using the graphical 
lasso. The edges are colored by the sign of the partial correlation (blue = negative, red = positive).
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the brain network for each subject in the HC group at each visit separately. Then, we fit models using amyloid sta-
tus to predict global efficiency, characteristic path length, and mean clustering coefficient at baseline and one-year 
follow up. Amyloid status was not a statistically significant predictor of any of these metrics after correcting for 
multiple testing. As a follow-up analysis, we used BJNL to jointly estimate the brain networks for both amyloid 
based subgroups at baseline and at one-year. We then examined the distribution of partial correlation differences 
between groups at each time point, corrected for multiple comparisons. We found that there were 10.8% and 
11.5% edges with significantly different strengths between the two groups at baseline and one year respectively. 
The results of the two analyses suggest that there are some differences between the amyloid positive and negative 
groups in connectivity strengths, but these differences in edge strengths do not dramatically alter the overall pat-
terns of information transmission in the brain as encapsulated via network metrics.
Although the main focus in this article is finding brain network-based differences between AD and HC 
cohorts, we also note that another topic of interest in literature is the brain networks of MCI subjects. We 
performed a supplementary analysis of early and late MCI amyloid positive individuals (14 EMCI and 14 
LMCI) that is similar to the analysis that was performed for the HC and AD patients. We saw a general increas-
ing trend in the number of edges as impairment progressed from healthy to Alzheimer’s. We also saw some 
network metric differences between the MCI group and the AD group, and these MCI network metrics often 
seemed to lie in between the HC and the AD network metrics indicating some progression of the disorder in 
the MCI cohort. The details for this analysis can be found in the Supplementary Materials. Another feature 
of the MCI network is the pattern of reduced between-network anticorrelation compared to healthy elders48, 
particularly between seed voxels present in the default mode network (DMN) and the dorsal attention network 
(DAN). We performed additional analysis to examine whether the anticorrelation (measured as the strength 
of negative connections) between the DMN (58 nodes) and the DAN (11 nodes) under the Power atlas, was 
reduced in the EMCI and LMCI groups compared to the HC cohort at baseline and one-year follow up. We 
did not find significantly reduced anticorrelation in any of the cohorts relative to the other cohorts. However, 
when we expanded the analysis to include both amyloid positive and negative MCI individuals (24 EMCI and 
23 LMCI), our results revealed a significantly reduced anticorrelation in the EMCI network compared to the 
HC network. Hence our region level analysis seems at least partially support existing evidence of reduced anti-
correlation in MCI individuals Table 9.
Node RSN HC Baseline HC One-year AD Baseline AD One-year AD − HC Baseline AD − HC One-year
207 FPR −0.83 −0.93 −0.86 −0.82 −0.02 0.12
259 Unk −0.79 −0.84 −0.92 −0.89 −0.13 −0.04
252 Unk −0.79 −0.91 −0.86 −0.85 −0.07 0.06
149 EC −0.8 −0.88 −0.89 −0.8 −0.09 0.09
211 FPR −0.8 −0.89 −0.79 −0.77 0 0.12
51 DMN −0.81 −0.82 −0.88 −0.81 −0.07 0.01
143 EC −0.8 −0.88 −0.83 −0.79 −0.03 0.09
195 FPL −0.84 −0.88 −0.88 −0.85 −0.04 0.03
208 FPR −0.76 −0.88 −0.81 −0.82 −0.05 0.06
164 EC −0.82 −0.84 −0.88 −0.79 −0.06 0.05
Table 7. Top 10 largest percent change in global efficiency upon removal of a node in HC and AD using the 
graphical lasso. Positive (negative) values indicate that removal of this node increased (decreased) the global 
efficiency. The final two columns display the difference in percent change between AD and HC at that node at 
baseline and at one-year.
Node RSN HC Baseline HC One-year AD Baseline AD One-year AD − HC Baseline AD − HC One-year
*128 Aud −0.01 −0.2 −0.09 −0.07 −0.08 0.13
*107 Aud −0.02 −0.18 −0.06 −0.08 −0.04 0.1
*114 Aud 0 −0.09 −0.17 −0.08 −0.17 0.01
*123 Aud −0.01 −0.09 −0.17 −0.08 −0.16 0.01
207 FPR 0.06 0.17 0.07 0.04 0.01 −0.13
110 Aud 0 0.15 0.03 0 0.03 −0.14
252 Unk 0.02 0.12 0.07 0.07 0.05 −0.06
149 EC 0.03 0.12 0.09 0.03 0.06 −0.09
169 EC 0.02 0.12 0.03 0.03 0.01 −0.09
164 EC 0.04 0.07 0.12 0.02 0.08 −0.04
Table 8. Top 10 largest percent change in CPL upon removal of a node in HC and AD using the graphical 
lasso. Positive (negative) values indicate that removal of this node increased (decreased) the CPL. The final two 
columns display the difference in percent change between AD and HC at that node at baseline and at one-year. 
A *before a node indicates that it was not a hub in any of the cohorts/visits, as identified by the graphical lasso.
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Finally, we note that there is a growing consensus among neuroradiologists that brain hypoperfusion is likely 
involved in the pathogenesis of AD and that disturbed cerebral blood flow (CBF) can serve as a promising bio-
marker for predicting conversion of mild cognitive impairment to AD49,50. In future work, it would be interesting 
to examine if these cerebral haemodynamic changes are correlated with loss of small-worldedness properties in 
AD individuals, compared to the HC cohort. Such an effort would be instrumental in directly relating cerebral 
brain health with changes in the brain network topology, which could be of potential translational and clinical 
significance. We plan to investigate these questions in future work.
Data availability
Data used in our analysis were downloaded from the ADNI website (http://www.adni.loni.usc.edu) and is publicly 
available. The code used to produce the results will be made available by the authors on reasonable request.
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